CN Patent

CN103263668A — 利福昔明抗直肠功能障碍制剂

Assigned to Salix Pharmaceuticals Inc · Expires 2013-08-28 · 13y expired

What this patent protects

本发明涉及利福昔明抗直肠功能障碍制剂。本发明涉及治疗直肠病症的组合物和方法。

USPTO Abstract

本发明涉及利福昔明抗直肠功能障碍制剂。本发明涉及治疗直肠病症的组合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103263668A
Jurisdiction
CN
Classification
—
Expires
2013-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Salix Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.